GNH USA

Europe — EMA

Orkambi (Lumacaftor, Ivacaftor)

Lumacaftor, the active ingredient in Orkambi, the active ingredient in Orkambi, is a combination product presented as a oral tablet for oral use.

Request sourcing

1
Pack/s

What is Lumacaftor, Ivacaftor?

Lumacaftor, the active ingredient in Orkambi, the active ingredient in Orkambi, is a combination product presented as a oral tablet for oral use. It treats cystic fibrosis in patients who have two copies of the F508del mutation.

GNH USA supplies Orkambi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Lumacaftor, Ivacaftor used for?

Orkambi acts ​        ​  ​  ​      ​                       ​         ...  …  …  ... …  … … ....  …  … … …  …  … """  " ""  " … " … "" " " …  " … … " …  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Lumacaftor, Ivacaftor
Route
Oral Use
Manufacturer
Vertex Pharmaceuticals (Ireland) Limited
Origin
EU

Related products